JPMorgan Chase & Co’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11K | Sell |
2,260
-26,003
| -92% | -$58.8K | ﹤0.01% | 5536 |
|
|
2025
Q1 | $75.5K | Sell |
28,263
-31,002
| -52% | -$82.8K | ﹤0.01% | 4869 |
|
|
2024
Q4 | $209K | Buy |
59,265
+44,311
| +296% | +$156K | ﹤0.01% | 4515 |
|
|
2024
Q3 | $70.9K | Buy |
14,954
+277
| +2% | +$1.31K | ﹤0.01% | 4860 |
|
|
2024
Q2 | $69K | Buy |
+14,677
| New | +$69K | ﹤0.01% | 4781 |
|
|
2023
Q2 | – | Sell |
-250
| Closed | -$1.7K | – | 5961 |
|
|
2023
Q1 | $1.7K | Buy |
+250
| New | +$1.7K | ﹤0.01% | 5599 |
|
|
2019
Q3 | – | Sell |
-60
| Closed | -$2K | – | 4749 |
|
|
2019
Q2 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 4754 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4440 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4058 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4229 |
|